US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 86.220
  • -0.210-0.24%
Trading Nov 27 12:26 ET
9.14BMarket Cap-99103P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Q3 2024 Earnings Date

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
172.35M
175.38M
+3.02M
Beat Est.
+36.60%
+39.00%
+1.75%
EPS
-0.21
-0.25
-0.04
Miss Est.
+16.37%
--
-19.62%
Strong Buy

Nov 19, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 198.200M--
--2024/Q4-- / 194.024M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 198.200M--
--2024/Q4-- / 194.024M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Nov 19, 2024

Strong Buy

  • Buy

    86.67%
  • Hold

    13.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data